PROGRAM MAY NO LONGER BE AVAILABLE: Takeda Oncology Here2Assist RapidStart Program: Iclusig

Funded
About
The Takeda Oncology Here2Assist RapidStart Program for Iclusig offers significant benefits for patients starting their Iclusig therapy. This program ensures that eligible patients who face delays in insurance coverage determination receive a 1-month supply of Iclusig at no charge. By enrolling in the Takeda Oncology Here2Assist program, patients can receive critical support exactly when they need it. Designed to aid those new to therapy, the RapidStart Program serves as a vital resource for uninterrupted access to necessary treatment.
Insurance requirements: Commercially insured, Underinsured
Enrollment Forms
Enrollment Form
Benefits
1 maximum fills per year
Program Requirements
Enrollment Required: Yes
Coverage Required: No
Needs Based: No
Activation Required: No
Program Details
The RapidStart Program provides a 1month supply of treatment of the prescribed Takeda Oncology medication at no charge for eligible patients new to therapy experiencing a delay in insurance coverage determination
Free product for the RapidStart Program will only be available through the RapidStart Program noncommercial specialty pharmacy
A delay in coverage determination of at least 5 days is required for patients to be eligible for the RapidStart Program
For assistance or additional information, call 8448176468, Option 2, MondayFriday, 8AM8PM ET